Appendix 4C

Quarterly report for entities subject to Listing Rule 4.7B

+Rule 4.7B

Appendix 4C

Quarterly report for entities subject to Listing Rule 4.7B

Introduced 31/03/00 Amended 30/09/01, 24/10/05, 17/12/10, 01/09/16

Name of entity

BIOTRON LIMITED

ABN

Quarter ended ("current quarter")

60 086 399 144

30 September 2019

Consolidated statement of cash flows

Current quarter

Year to date (3

$A'000

months)

$A'000

1.

Cash flows from operating activities

1.1

Receipts from customers

-

-

1.2

Payments for

(a)

research and development

(516)

(516)

(b)

product manufacturing and operating

costs

-

-

(c)

advertising and marketing

(d)

leased assets

-

-

(e)

staff costs

(196)

(196)

(f)

administration and corporate costs

(196)

(196)

1.3

Dividends received (see note 3)

-

-

1.4

Interest received

27

27

1.5

Interest and other costs of finance paid

-

-

1.6

Income taxes paid

-

-

1.7

Government grants and tax incentives

-

-

1.8

Other

-

-

1.9

Net cash from / (used in) operating

(881)

(881)

activities

2.

Cash flows from investing activities

2.1

Payments to acquire:

(a) property, plant and equipment

-

-

(b) businesses (see item 10)

-

-

(c) investments

-

-

+ See chapter 19 for defined terms

1 September 2016

Page 1

Appendix 4C

Quarterly report for entities subject to Listing Rule 4.7B

Consolidated statement of cash flows

Current quarter

Year to date (3

$A'000

months)

$A'000

(d)

intellectual property

-

-

(e)

other non-current assets

-

-

2.2

Proceeds from disposal of:

(a) property, plant and equipment

-

-

(b) businesses (see item 10)

-

-

(c)

investments

-

-

(d)

intellectual property

-

-

(e)

other non-current assets

-

-

2.3

Cash flows from loans to other entities

-

-

2.4

Dividends received (see note 3)

-

-

2.5

Other - Rental Bond

-

-

2.6

Net cash from / (used in) investing

-

-

activities

3. Cash flows from financing activities

3.1

Proceeds from issues of shares

-

-

3.2

Proceeds from issue of convertible notes

-

-

3.3

Proceeds from exercise of share options

5

5

3.4 Transaction costs related to issues of

shares, convertible notes or options

-

-

3.5

Proceeds from borrowings

-

-

3.6

Repayment of borrowings

-

-

3.7 Transaction costs related to loans and

borrowings

-

-

3.8

Dividends paid

-

-

3.9 Other - Consideration received for exercise

of Options.

-

-

3.10 Net cash from / (used in) financing

5

5

activities

4. Net increase / (decrease) in cash and cash equivalents for the period

4.1 Cash and cash equivalents at beginning of

quarter/year to date

5,740

5,740

4.2 Net cash from / (used in) operating

activities (item 1.9 above)

(881)

(881)

4.3 Net cash from / (used in) investing activities

(item 2.6 above)

-

-

4.4 Net cash from / (used in) financing activities

(item 3.10 above)

5

5

+ See chapter 19 for defined terms

1 September 2016

Page 2

Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B

Consolidated statement of cash flows

  1. Effect of movement in exchange rates on cash held
  2. Cash and cash equivalents at end of quarter

5. Reconciliation of cash and cash equivalents

at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

5.1 Bank balances

  1. Call deposits
  2. Bank overdrafts
  3. Other (provide details)
  4. Cash and cash equivalents at end of quarter (should equal item 4.6 above)

Current quarter

$A'000

-

4,864

Current quarter

$A'000

2,864

2,000

-

-

4,864

Year to date (3

months)

$A'000

-

4,864

Previous quarter

$A'000

680

5,060

-

-

5,740

6. Payments to directors of the entity and their associates

Current quarter

$A'000

6.1

Aggregate amount of payments to these parties included in item 1.2

147

6.2 Aggregate amount of cash flow from loans to these parties included

in item 2.3

-

6.3 Include below any explanation necessary to understand the transactions included in items 6.1 and 6.2

Payments in 6.1 are payments to the Directors of the Company.

7. Payments to related entities of the entity and their associates

  1. Aggregate amount of payments to these parties included in item 1.2
  2. Aggregate amount of cash flow from loans to these parties included in item 2.3

Current quarter

$A'000

57

-

7.3 Include below any explanation necessary to understand the transactions included in items 7.1 and 7.2

Payments in 7.1 are to Rosignol Consultants Pty Limited ('Rosignol') ($21,000) and MIS Corporate Pty Limited ('MIS') ($36,000), entities in which Peter Nightingale holds a controlling interest. Rosignol provides company secretarial services and MIS provides administrative and accounting services, as well as rental accommodation to Biotron Limited.

+ See chapter 19 for defined terms

1 September 2016

Page 3

Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B

8. Financing facilities available

Add notes as necessary for an understanding of the position

Total facility amount

Amount drawn at

at quarter end

quarter end

$A'000

$A'000

8.1

Loan facilities

-

-

8.2

Credit standby arrangements

-

-

8.3

Other (please specify)

-

-

8.4 Include below a description of each facility above, including the lender, interest rate and whether it is secured or unsecured. If any additional facilities have been entered into or are proposed to be entered into after quarter end, include details of those facilities as well.

N/A

9.

Estimated cash outflows for next quarter

$A'000

9.1

Research and development

1,289

9.2

Product manufacturing and operating costs

-

9.3

Advertising and marketing

-

9.4

Leased assets

-

9.5

Staff costs

195

9.6

Administration and corporate costs

357

9.7

Other

-

9.8

Total estimated cash outflows

1,841

10.

Acquisitions and disposals of

Acquisitions

Disposals

business entities

(items 2.1(b) and 2.2(b) above)

10.1

Name of entity

-

-

10.2 Place of incorporation or

registration

-

-

10.3

Consideration for acquisition or

disposal

-

-

10.4

Total net assets

-

-

10.5

Nature of business

-

-

+ See chapter 19 for defined terms

1 September 2016

Page 4

Appendix 4C

Quarterly report for entities subject to Listing Rule 4.7B

Compliance statement

  • This statement has been prepared in accordance with accounting standards and policies which comply with Listing Rule 19.11A.
  • This statement gives a true and fair view of the matters disclosed.

Sign here:

............................................................ Date: 21 October 2019

Company Secretary

Print name:

Peter J. Nightingale

Notes

  1. The quarterly report provides a basis for informing the market how the entity's activities have been financed for the past quarter and the effect on its cash position. An entity that wishes to disclose additional information is encouraged to do so, in a note or notes included in or attached to this report.
  2. If this quarterly report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 107: Statement of Cash Flows apply to this report. If this quarterly report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing Rule 19.11A, the corresponding equivalent standard applies to this report.
  3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

+ See chapter 19 for defined terms

1 September 2016

Page 5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Biotron Limited published this content on 21 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 October 2019 05:30:09 UTC